Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)

SHE:000766 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	1,323	1,322	1,470	1,470	1,514	1,111
Other Revenue	0.41	0.5	3.57	0.58	1.32	0.72
Revenue	1,323	1,323	1,473	1,471	1,515	1,112
Revenue Growth (YoY)	-5.07%	-10.23%	0.18%	-2.95%	36.31%	-43.77%
Cost of Revenue	339.4	329.03	381.17	352.93	350.18	229.94
Gross Profit	983.96	993.53	1,092	1,118	1,165	881.86
Selling, General & Admin	762.8	789.26	905	923.47	986.24	1,042
Research & Development	50.63	50.34	45.82	64.91	63.52	50.33
Other Operating Expenses	17.87	9.88	10.62	11.57	5.4	3.96
Operating Expenses	834.86	853.14	970.43	996.86	1,052	1,228
Operating Income	149.1	140.39	121.75	120.96	113.33	-346.24
Interest Expense	-85.15	-84.98	-83.15	-88.79	-97.19	-125.27
Interest & Investment Income	3.72	5.28	4.02	11.5	26.36	23.31
Other Non Operating Income (Expenses)	-1.82	-2.66	1.23	-3.64	3.47	-0.37
EBT Excluding Unusual Items	65.86	58.03	43.85	40.02	45.98	-448.58
Gain (Loss) on Sale of Investments	-0	0.03	-2.61	-0.05	-0.01	-
Gain (Loss) on Sale of Assets	-0.03	-0.17	-0.21	-0.02	0.83	57.58
Asset Writedown	-0.03	-0.12	0.22	-0.11	-1.49	-0.43
Other Unusual Items	11.92	9.32	13.61	10.33	14.32	35.6
Pretax Income	77.72	67.09	54.86	50.17	59.62	-355.83
Income Tax Expense	17.24	11.11	11.63	20.99	25.64	4.83
Earnings From Continuing Operations	60.48	55.98	43.23	29.19	33.99	-360.66
Minority Interest in Earnings	0.3	0.46	0.71	0.96	1.29	1.16
Net Income	60.77	56.44	43.93	30.15	35.27	-359.5
Net Income to Common	60.77	56.44	43.93	30.15	35.27	-359.5
Net Income Growth	33.20%	28.46%	45.71%	-14.52%	-	-
Shares Outstanding (Basic)	940	941	879	1,005	882	972
Shares Outstanding (Diluted)	940	941	879	1,005	882	972
Shares Change (YoY)	6.74%	7.05%	-12.57%	13.97%	-9.24%	0.40%
EPS (Basic)	0.06	0.06	0.05	0.03	0.04	-0.37
EPS (Diluted)	0.06	0.06	0.05	0.03	0.04	-0.37
EPS Growth	24.79%	20.00%	66.67%	-25.00%	-	-
Free Cash Flow	158.99	113.58	86.11	174.42	112.85	61.55
Free Cash Flow Per Share	0.17	0.12	0.10	0.17	0.13	0.06
Gross Margin	74.35%	75.12%	74.13%	76.00%	76.89%	79.32%
Operating Margin	11.27%	10.62%	8.26%	8.22%	7.48%	-31.14%
Profit Margin	4.59%	4.27%	2.98%	2.05%	2.33%	-32.34%
Free Cash Flow Margin	12.01%	8.59%	5.85%	11.86%	7.45%	5.54%
EBITDA	210.65	204.82	196.49	192.58	182.72	-278.53
EBITDA Margin	15.92%	15.49%	13.34%	13.09%	12.06%	-25.05%
D&A For EBITDA	61.55	64.42	74.74	71.62	69.39	67.71
EBIT	149.1	140.39	121.75	120.96	113.33	-346.24
EBIT Margin	11.27%	10.62%	8.26%	8.22%	7.48%	-31.14%
Effective Tax Rate	22.19%	16.56%	21.20%	41.83%	42.99%	-
Revenue as Reported	1,323	1,323	1,473	1,471	1,515	1,112
Advertising Expenses	-	249.73	352.83	298.68	375.06	299.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.